Julia Marie Eastland, CEO and President of Zentalis Pharmaceuticals ($ZNTL), sold shares on the open market twice in the last year, totaling $21,239. Her most recent sale occurred on February 9, 2026. These sales rank her 11,004th among 11,678 insiders in our database by value sold, well below the average of $8.6 million across about six transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 9, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | S | Common Stock | 889 | $2.39 | 79,133.0000 | 72,250,779 | 1.11% | 0.00% |
| Feb. 6, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | S | Common Stock | 7866 | $2.43 | 80,022.0000 | 72,250,779 | 8.95% | 0.01% |
| Jan. 8, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | A | Stock Option (Right to Buy) | 775000 | $0.00 | 775,000.0000 | 72,250,779 | 9999.99% | 1.07% |
| May 14, 2025 | Lantheus Holdings, Inc. | $LNTH | EASTLAND JULIA MARIE | Director | A | Common Stock | 2537 | $0.00 | 3,882.0000 | 71,651,000 | 188.62% | 0.00% |
| May 14, 2025 | Lantheus Holdings, Inc. | $LNTH | EASTLAND JULIA MARIE | Director | A | Stock Option (right to buy) | 4543 | $0.00 | 4,543.0000 | 71,651,000 | 9999.99% | 0.01% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | A | Common Stock | 59388 | $0.00 | 87,888.0000 | 0 | 208.38% | 0.00% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | A | Stock Option (Right to Buy) | 59388 | $0.00 | 59,388.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | P | Common Stock | 28500 | $1.73 | 28,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | EASTLAND JULIA MARIE | CEO & President | A | Stock Option (Right to Buy) | 3028800 | $0.00 | 3,028,800.0000 | 0 | 9999.99% | 0.00% |
| Sept. 10, 2024 | Lantheus Holdings, Inc. | $LNTH | EASTLAND JULIA MARIE | Director | A | Stock Option (right to buy) | 2506 | $0.00 | 2,506.0000 | 70,239,000 | 9999.99% | 0.00% |
| Sept. 10, 2024 | Lantheus Holdings, Inc. | $LNTH | EASTLAND JULIA MARIE | Director | A | Common Stock | 1345 | $0.00 | 1,345.0000 | 70,239,000 | 9999.99% | 0.00% |
| May 23, 2024 | DYNAVAX TECHNOLOGIES CORP | $DVAX | EASTLAND JULIA MARIE | Not found | A | Stock Option (Right to Buy) | 22500 | $0.00 | 22,500.0000 | 128,733,000 | 9999.99% | 0.02% |
| May 23, 2024 | DYNAVAX TECHNOLOGIES CORP | $DVAX | EASTLAND JULIA MARIE | Not found | A | Common Stock | 5357 | $0.00 | 16,071.0000 | 128,733,000 | 50.00% | 0.00% |